share_log

BMO Capital Upgrades Chemours to Outperform, Raises Price Target to $34

Benzinga ·  Apr 9 17:48

BMO Capital analyst John McNulty upgrades Chemours (NYSE:CC) from Market Perform to Outperform and raises the price target from $19 to $34.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment